2019 Clinical practice guidelines for type 2 diabetes mellitus in Korea

Committee of Clinical Practice Guidelines, Korean Diabetes Association

Research output: Contribution to journalArticleResearchpeer-review

Abstract

The Committee of Clinical Practice Guidelines of the Korean Diabetes Association revised and updated the 6th Clinical Practice Guidelines in 2019. Targets of glycemic, blood pressure, and lipid control in type 2 diabetes mellitus (T2DM) were updated. The obese and overweight population is increasing steadily in Korea, and half of the Koreans with diabetes are obese. Evidence-based recommendations for weight-loss therapy for obesity management as treatment for hyperglycemia in T2DM were provided. In addition, evidence from large clinical studies assessing cardiovascular outcomes following the use of sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide 1 receptor agonists in patients with T2DM were incorporated into the recommendations.

Original languageEnglish
Pages (from-to)398-406
Number of pages9
JournalDiabetes and Metabolism Journal
Volume43
Issue number4
DOIs
StatePublished - 2019 Aug 1

Fingerprint

Korea
Practice Guidelines
Type 2 Diabetes Mellitus
Sodium-Glucose Transport Proteins
Hyperglycemia
Weight Loss
Obesity
Blood Pressure
Lipids
Therapeutics
Population

Keywords

  • Diabetes mellitus, type 2
  • Diagnosis
  • Practice guideline
  • Therapeutics

Cite this

Committee of Clinical Practice Guidelines, & Korean Diabetes Association (2019). 2019 Clinical practice guidelines for type 2 diabetes mellitus in Korea. Diabetes and Metabolism Journal, 43(4), 398-406. https://doi.org/10.4093/dmj.2019.0137
Committee of Clinical Practice Guidelines ; Korean Diabetes Association. / 2019 Clinical practice guidelines for type 2 diabetes mellitus in Korea. In: Diabetes and Metabolism Journal. 2019 ; Vol. 43, No. 4. pp. 398-406.
@article{e60a26c3147049049ca3d0168cac235d,
title = "2019 Clinical practice guidelines for type 2 diabetes mellitus in Korea",
abstract = "The Committee of Clinical Practice Guidelines of the Korean Diabetes Association revised and updated the 6th Clinical Practice Guidelines in 2019. Targets of glycemic, blood pressure, and lipid control in type 2 diabetes mellitus (T2DM) were updated. The obese and overweight population is increasing steadily in Korea, and half of the Koreans with diabetes are obese. Evidence-based recommendations for weight-loss therapy for obesity management as treatment for hyperglycemia in T2DM were provided. In addition, evidence from large clinical studies assessing cardiovascular outcomes following the use of sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide 1 receptor agonists in patients with T2DM were incorporated into the recommendations.",
keywords = "Diabetes mellitus, type 2, Diagnosis, Practice guideline, Therapeutics",
author = "{Committee of Clinical Practice Guidelines} and {Korean Diabetes Association} and Kim, {Mee Kyoung} and Ko, {Seung Hyun} and Kim, {Bo Yeon} and Kang, {Eun Seok} and Junghyun Noh and Kim, {Soo Kyung} and Park, {Seok O.} and Hur, {Kyu Yeon} and Suk Chon and Moon, {Min Kyong} and Kim, {Nan Hee} and Kim, {Sang Yong} and Rhee, {Sang Youl} and Lee, {Kang Woo} and Kim, {Jae Hyeon} and Rhee, {Eun Jung} and Chun, {Sung Wan} and Yu, {Sung Hoon} and Kim, {Dae Jung} and Kwon, {Hyuk Sang} and Park, {Kyong Soo}",
year = "2019",
month = "8",
day = "1",
doi = "10.4093/dmj.2019.0137",
language = "English",
volume = "43",
pages = "398--406",
journal = "Diabetes and Metabolism Journal",
issn = "2233-6079",
number = "4",

}

Committee of Clinical Practice Guidelines & Korean Diabetes Association 2019, '2019 Clinical practice guidelines for type 2 diabetes mellitus in Korea', Diabetes and Metabolism Journal, vol. 43, no. 4, pp. 398-406. https://doi.org/10.4093/dmj.2019.0137

2019 Clinical practice guidelines for type 2 diabetes mellitus in Korea. / Committee of Clinical Practice Guidelines; Korean Diabetes Association.

In: Diabetes and Metabolism Journal, Vol. 43, No. 4, 01.08.2019, p. 398-406.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - 2019 Clinical practice guidelines for type 2 diabetes mellitus in Korea

AU - Committee of Clinical Practice Guidelines

AU - Korean Diabetes Association

AU - Kim, Mee Kyoung

AU - Ko, Seung Hyun

AU - Kim, Bo Yeon

AU - Kang, Eun Seok

AU - Noh, Junghyun

AU - Kim, Soo Kyung

AU - Park, Seok O.

AU - Hur, Kyu Yeon

AU - Chon, Suk

AU - Moon, Min Kyong

AU - Kim, Nan Hee

AU - Kim, Sang Yong

AU - Rhee, Sang Youl

AU - Lee, Kang Woo

AU - Kim, Jae Hyeon

AU - Rhee, Eun Jung

AU - Chun, Sung Wan

AU - Yu, Sung Hoon

AU - Kim, Dae Jung

AU - Kwon, Hyuk Sang

AU - Park, Kyong Soo

PY - 2019/8/1

Y1 - 2019/8/1

N2 - The Committee of Clinical Practice Guidelines of the Korean Diabetes Association revised and updated the 6th Clinical Practice Guidelines in 2019. Targets of glycemic, blood pressure, and lipid control in type 2 diabetes mellitus (T2DM) were updated. The obese and overweight population is increasing steadily in Korea, and half of the Koreans with diabetes are obese. Evidence-based recommendations for weight-loss therapy for obesity management as treatment for hyperglycemia in T2DM were provided. In addition, evidence from large clinical studies assessing cardiovascular outcomes following the use of sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide 1 receptor agonists in patients with T2DM were incorporated into the recommendations.

AB - The Committee of Clinical Practice Guidelines of the Korean Diabetes Association revised and updated the 6th Clinical Practice Guidelines in 2019. Targets of glycemic, blood pressure, and lipid control in type 2 diabetes mellitus (T2DM) were updated. The obese and overweight population is increasing steadily in Korea, and half of the Koreans with diabetes are obese. Evidence-based recommendations for weight-loss therapy for obesity management as treatment for hyperglycemia in T2DM were provided. In addition, evidence from large clinical studies assessing cardiovascular outcomes following the use of sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide 1 receptor agonists in patients with T2DM were incorporated into the recommendations.

KW - Diabetes mellitus, type 2

KW - Diagnosis

KW - Practice guideline

KW - Therapeutics

UR - http://www.scopus.com/inward/record.url?scp=85072118225&partnerID=8YFLogxK

U2 - 10.4093/dmj.2019.0137

DO - 10.4093/dmj.2019.0137

M3 - Article

VL - 43

SP - 398

EP - 406

JO - Diabetes and Metabolism Journal

JF - Diabetes and Metabolism Journal

SN - 2233-6079

IS - 4

ER -

Committee of Clinical Practice Guidelines, Korean Diabetes Association. 2019 Clinical practice guidelines for type 2 diabetes mellitus in Korea. Diabetes and Metabolism Journal. 2019 Aug 1;43(4):398-406. https://doi.org/10.4093/dmj.2019.0137